Literature DB >> 26345189

Constipation preceding Parkinson's disease: a systematic review and meta-analysis.

Kerala L Adams-Carr1, Jonathan P Bestwick2, Samuel Shribman3, Andrew Lees4, Anette Schrag4, Alastair J Noyce4.   

Abstract

OBJECTIVE: To systematically review published literature to estimate the magnitude of association between premorbid constipation and later diagnosis of Parkinson's disease.
BACKGROUND: Constipation is a recognised non-motor feature of Parkinson's and has been reported to predate diagnosis in a number of observational studies.
METHODS: A systematic review and meta-analysis was carried out following the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) criteria. A literature search was undertaken in December 2014 using PubMed and the search terms 'Parkinson's disease' and 'constipation'. Articles were screened for suitability and reviewed against inclusion and exclusion criteria. Studies were included if they assessed constipation by means of a structured questionnaire or if constipation/drugs used to treat constipation were coded in patient medical records. Data were extracted using a standardised template and effect size estimates combined using a fixed-effects model. Heterogeneity was explored with the I(2) statistic.
RESULTS: 9 studies were included in the meta-analysis, with a combined sample size of 741 593 participants. Those with constipation had a pooled OR of 2.27 (95% CI 2.09 to 2.46) for developing subsequent Parkinson's disease compared with those without constipation. Weak evidence for heterogeneity was found (I(2)=18.9%, p=0.282). Restricting analysis to studies assessing constipation more than 10 years prior to Parkinson's disease gave a pooled OR of 2.13 (95% CI 1.78 to 2.56; I(2)=0.0%).
CONCLUSIONS: This systematic review and meta-analysis demonstrates that people with constipation are at a higher risk of developing Parkinson's disease compared with those without and that constipation can predate Parkinson's diagnosis by over a decade. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Mesh:

Year:  2015        PMID: 26345189     DOI: 10.1136/jnnp-2015-311680

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  44 in total

1.  Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.

Authors:  Abby L Olsen; Mel B Feany
Journal:  Glia       Date:  2019-07-03       Impact factor: 7.452

2.  Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.

Authors:  Yuki Kishimoto; Wandi Zhu; Waki Hosoda; Jyoti M Sen; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2019-05-11       Impact factor: 3.843

3.  Alzheimer's Disease and Parkinson's Disease May Result from Reactivation of Embryologic Pathways Silenced at Birth.

Authors:  Steven Lehrer; Peter H Rheinstein
Journal:  Discov Med       Date:  2021 Mar-Apr       Impact factor: 2.970

Review 4.  A Critical Analysis of Intestinal Enteric Neuron Loss and Constipation in Parkinson's Disease.

Authors:  Chelsea O'Day; David Isaac Finkelstein; Shanti Diwakarla; Rachel Mai McQuade
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

5.  Analysis of the clinical features of early Parkinson's disease with comparatively integrated intestinal function.

Authors:  Xiaoxue Guan; Yuchan Wang; Qun Li; Ming Wei; Lili Chen; Oumei Cheng
Journal:  Neurol Sci       Date:  2018-07-17       Impact factor: 3.307

6.  Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case-Control Study in an Australian Cohort.

Authors:  Jade E Kenna; Megan C Bakeberg; Anastazja M Gorecki; Alfred Chin Yen Tay; Samantha Winter; Frank L Mastaglia; Ryan S Anderton
Journal:  Mov Disord Clin Pract       Date:  2021-01-05

7.  Early constipation predicts faster dementia onset in Parkinson's disease.

Authors:  M Camacho; A D Macleod; J Maple-Grødem; J R Evans; D P Breen; G Cummins; R S Wijeyekoon; J C Greenland; G Alves; O B Tysnes; R A Lawson; R A Barker; C H Williams-Gray
Journal:  NPJ Parkinsons Dis       Date:  2021-05-26

8.  Irritable Bowel Syndrome and Risk of Parkinson's Disease in Finland: A Nationwide Registry-Based Cohort Study.

Authors:  Tuomas H Mertsalmi; Anna But; Eero Pekkonen; Filip Scheperjans
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

9.  Use of medical care biases associations between Parkinson disease and other medical conditions.

Authors:  Anat Gross; Brad A Racette; Alejandra Camacho-Soto; Umber Dube; Susan Searles Nielsen
Journal:  Neurology       Date:  2018-05-09       Impact factor: 9.910

Review 10.  Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease.

Authors:  Marina Picillo; Paolo Barone; Maria Teresa Pellecchia
Journal:  Mov Disord Clin Pract       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.